| Financial Year |
March 31 2023 |
| Monetary Funds |
199,872,639.73 |
| Held-for-trading Financial Assets |
120,000,000.00 |
| Notes Receivable |
91,179,205.26 |
| Accounts Receivable |
185,192,580.29 |
| Advances to Suppliers |
74,170,208.23 |
| Other Receivables |
2,318,375.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
603,176,276.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,390,196.75 |
| Total Current Assets |
1,296,237,191.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,159,373,978.22 |
| Under-construction Projects |
281,901,239.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,732,000.99 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
105,282,966.37 |
| Deferred Income Tax Assets |
2,091,215.42 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,569,381,400.89 |
| Total Assets |
2,865,618,592.35 |
| Short-Term Loans |
207,600,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
97,116,256.98 |
| Accounts Payable |
174,166,883.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,233,408.41 |
| Taxes Payable |
50,021,031.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,472,091.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,501,305.27 |
| Other Current Liabilities |
74,529,764.36 |
| Sub-Total of Current Liabilities |
729,865,862.86 |
| Long-term Loans |
25,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
189,243,750.16 |
| Sub-Total of Non-Current Liabilities |
225,721,490.64 |
| Total Liabilities |
955,587,353.50 |
| Paid-In Capital(Or Share Stock) |
695,263,035.00 |
| Capital Surplus |
1,958,304,301.50 |
| Surplus Reserve |
69,030,441.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-845,783,411.76 |
| Minority Stockholder's Interest |
33,216,872.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,876,814,365.91 |
| Owner's Equity（Stockholder's Equity） |
1,910,031,238.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,865,618,592.35 |
